Biotavia

Delhi, India
Manufacturing and trading of high-quality Active Pharmaceutical Ingredients and Intermediates in India.

About Biotavia

Biotavia is a Chemicals & Materials company based in Delhi (India). Manufacturing and trading of high-quality Active Pharmaceutical Ingredients and Intermediates in India. It operates in the Chemicals & Materials and Healthcare sectors. The company has 4 employees. Its Indian entity Biotavia Labs Private Limited reported revenue of β‚Ή83.55 Cr. Biotavia offers products and services including Amoxycillin Trihydrate and Ofloxacin. Its focus areas include Pharmaceuticals, Chemical Intermediates, Intermediates Trading and Quality Assurance Processes.

Company details

Biotavia has been recognized as a leading supplier of APIs in India over the past 20 years, with growth achieved through manufacturing and trading of high-quality Active Pharmaceutical Ingredients and Intermediates. Quality assurance systems and predefined documentation processes are implemented in manufacturing and purchasing operations. The company is noted for cooperating with pharmaceutical companies as a reliable supplier, emphasizing superior service and adherence to ethical business practices guided by ethics, honesty, and transparency.

  • Headquarters Delhi, India
  • Employees 4
  • Sectors
    Chemicals & Materials
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website biotavia.com
  • Legal Name Biotavia Labs Pvt. Ltd
  • Date of Incorporation 29 Sep, 2006
  • Jurisdiction Delhi, India
Key Metrics
  • Annual Revenue
    ₹83.55 Cr

    FY 2025 · -56% YoY

  • Net Loss
    -₹1.77 Cr

    FY 2025 · -2% margin

  • EBITDA
    ₹70.2 Lakh

    FY 2025 · 1% margin

  • Employee Count
    4

Products & Services of Biotavia

Biotavia offers a comprehensive portfolio of products and services, including Amoxycillin Trihydrate and Ofloxacin.

Amoxycillin Trihydrate
Active Pharmaceutical Ingredients

This product is manufactured and traded as a high-quality API for pharmaceutical use.

Ofloxacin
Active Pharmaceutical Ingredients

This product is included in the range of APIs that are supplied for various pharmaceutical applications.

Board of directors of Biotavia Labs Private Limited (Biotavia)

Biotavia Labs Private Limited is the primary company behind Biotavia. The board of Biotavia Labs Private Limited currently have 2 directors; the longest-serving is Vipul Goel, appointed in 2009. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vipul Goel
DIN 00064274
Director10 Apr 200917 yrs 7 moBiotavia Labs Private Limited
Sameer Goel
DIN 00161786
Director15 Jun 20215 yrs 5 moBiotavia Labs Private Limited

Financials of Biotavia

Figures of Biotavia Labs Private Limited, the primary company behind Biotavia, for FY 2025. Revenue was ₹83.55 Cr (-56% year on year). Net loss was -₹1.77 Cr (-2% margin). EBITDA was ₹70.2 Lakh (1% margin). Revenue has grown at a compounded annual rate of -17% over three years and -15% over five years.

  • ₹83.55 CrRevenue · FY 2025 · -56% YoY
  • -₹1.77 CrNet loss · -2% margin
  • ₹70.2 LakhEBITDA · 1% margin
  • ₹2.56 CrPaid-up capital
  • 4Employees (provident fund records)
  • -17%Revenue CAGR, 3 years
  • -15%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Biotavia Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Biotavia

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Chemical Distribution & Trade

3 companies that operate in the same segment as Biotavia (Chemical Distribution & Trade) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Dye chemicals are supplied to industrial sectors from India.
1980Bhilwara, Rajasthan, IndiaUSD 49.56 M9
Manufactures, distributes, and exports a range of chemical products globally.
1981Chennai, Tamil Nadu, India
CHD CHEMICALS
2012Chandigarh, IndiaUSD 3.82 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Biotavia

Biotavia is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Biotavia has 4 employees.

The primary company behind Biotavia, Biotavia Labs Private Limited, reported revenue of β‚Ή83.55 Cr for FY 2025, down 56% year on year.

Biotavia has been recognized as a leading supplier of APIs in India over the past 20 years, with growth achieved through manufacturing and trading of high-quality Active Pharmaceutical Ingredients and Intermediates. Quality assurance systems and predefined documentation processes are implemented in manufacturing and purchasing operations. The company is noted for cooperating with pharmaceutical companies as a reliable supplier, emphasizing superior service and adherence to ethical business practices guided by ethics, honesty, and transparency.

Biotavia offers Amoxycillin Trihydrate and Ofloxacin.

Biotavia operates through Biotavia Labs Private Limited.

The legal entities of Biotavia currently have 2 directors, including Vipul Goel, Sameer Goel.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available